N
Nicholas A. Christakis
Researcher at Yale University
Publications - 315
Citations - 52685
Nicholas A. Christakis is an academic researcher from Yale University. The author has contributed to research in topics: Population & Social network. The author has an hindex of 63, co-authored 307 publications receiving 48235 citations. Previous affiliations of Nicholas A. Christakis include Mount Auburn Hospital & University of Notre Dame.
Papers
More filters
Journal ArticleDOI
Evolution of in-group favoritism
TL;DR: A mathematical framework for the evolution of in-group favoritism from a continuum of strategies is proposed, not based on explicit intergroup conflict, but instead uses evolutionary set theory.
Journal ArticleDOI
Biases in how physicians choose to withdraw life support
TL;DR: Bias in physicians' decisions regarding the form of life support to withdraw from critically ill patients in whom the decision to withdraw has already been made may represent impediments to rational and compassionate decision making in critical care.
Journal ArticleDOI
Correlated genotypes in friendship networks
TL;DR: The results suggest that association tests should include friends’ genes and that theories of evolution should take into account the fact that humans might, in some sense, be metagenomic with respect to the humans around them.
Journal ArticleDOI
Mapping Physician Networks with Self‐Reported and Administrative Data
Michael L. Barnett,Bruce E. Landon,A. James O'Malley,Nancy L. Keating,Nicholas A. Christakis +4 more
TL;DR: Patient sharing identified using administrative data is an informative "diagnostic test" for predicting the existence of relationships between physicians, validates a method that can be used for future research to map networks of physicians.
Journal ArticleDOI
Complexities in prognostication in advanced cancer: "to help them live their lives the way they want to".
TL;DR: Clinical issues related to the science of prognosis in advanced cancer and the art of its disclosure are discussed and a real patient with advanced cancer who far outlived her physician's prognostic estimate is discussed.